Becton, Dickinson & Company (BDX)
74.46USD
10:42am EST
$-0.80 (-1.06%)
$75.26
$75.11
$75.25
$74.28
147,172
1,335,523
$79.97
$60.40
BDX
About
Overall
| Beta: | 0.60 |
| Market Cap (Mil.): | $17,738.73 |
| Shares Outstanding (Mil.): | 235.70 |
| Annual Dividend: | 1.48 |
| Yield (%): | 1.97 |
Financials
| BDX | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 15.11 | 4.05 | 3.76 |
| EPS (TTM): | 7.93 | -- | -- |
| ROI: | 17.96 | 2.37 | 2.30 |
| ROE: | 24.33 | 3.77 | 2.82 |
UPDATE 2-Becton Dickinson recalls intravenous devices
* Millions of recalled devices were distributed worldwide
WRAPUP 1-Baxter, Becton forecasts set bar too low-analysts
CHICAGO, Jan 28 (Reuters) - Three top medical device companies issued financial outlooks for 2010 that analysts characterized as "conservative," as executives seemed reluctant to get too bullish in the face of a sluggish economy.
UPDATE 1-Becton Dickinson posts higher quarterly profit
NEW YORK, Jan 28 (Reuters) - Becton Dickinson & Co reported a rise in quarterly profit as healthy demand for its medical and diagnostics devices drove revenue growth higher.
UPDATE 1-Becton Dickinson Q4 profit rises
Nov 4 (Reuters) - Diagnostic products maker Becton Dickinson & Co posted a 10 percent increase in fourth-quarter income from continuing operations, helped by higher sales at its medical and diagnostic units.
UPDATE 2-BioMerieux lifts forecast as U.S. demand returns
* 2009 operating margin seen above 17 pct vs about 17 pct
Rapid flu tests miss many swine flu cases: CDC
CHICAGO (Reuters) - A study of rapid influenza tests found they miss many cases of swine flu and U.S. health experts said on Thursday they are not worth the trouble for this flu season.
Rapid flu tests miss many swine flu cases - US CDC
* CDC says many people will not know what kind they have
HEADLINE STOCKS-Some U.S. stocks on the move on Sept 3
(Updates to after the open, adds Target, Gap, Macy's, JC Penney, Abercrombie, Family Dollar, Del Monte, Methode, Vical, Movado, Beckton Dickinson, Danaher, Teekay and Helicos)
UPDATE 1-Becton gets flu product order from U.S. government
* Gov't can buy $52 mln of flu products through March 2010
Competitors
| Price | Change | |
|---|---|---|
| Baxter International Inc. (BAX.N) | $56.01 | -0.37 |
| Hospira, Inc. (HSP.N) | $49.32 | -0.10 |
| TERUMO CORPORATION (4543.T) | ¥4,860.00 | -15.00 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
